drugset / Trial / NCT04599868

High Versus Low Dose of Magnesium Sulfate as Initial Tocolytic Agent for Preterm Labour in Symptomatic Placenta Previa.

NCT04599868

Phase 2 Completed 130 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the efficacy and safety of alternative magnesium sulfate regimens when used as single agent tocolytic therapy for prevention of preterm labour in patients with symptomatic placenta previa and subsequent changes in the cervical length .

Timeline

Start
2020-12-01
Primary completion
2022-08-20
Completion
2022-08-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 1 g Intravenous
Comparator Magnesium Sulfate Other / unclassified 2 g Intravenous

Indications